Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway

Background Most targeted anticancer therapies, as well as cytotoxic and radiation therapies, are encumbered by the development of secondary resistance by cancer cells. Resistance is a complex phenomenon involving multiple mechanisms, including activation of signaling pathways such as phosphatidylino...

Full description

Saved in:
Bibliographic Details
Published in:Cancer chemotherapy and pharmacology Vol. 71; no. 4; pp. 829 - 842
Main Author: Burris, Howard A.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer-Verlag 01.04.2013
Springer
Springer Nature B.V
Subjects:
ISSN:0344-5704, 1432-0843, 1432-0843
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first